vs
CUMBERLAND PHARMACEUTICALS INC（CPIX）与FIRST CAPITAL INC（FCAP）财务数据对比。点击上方公司名可切换其他公司
CUMBERLAND PHARMACEUTICALS INC的季度营收约是FIRST CAPITAL INC的1.0倍（$13.7M vs $13.5M），FIRST CAPITAL INC净利率更高（36.2% vs -10.3%，领先46.5%），CUMBERLAND PHARMACEUTICALS INC同比增速更快（31.1% vs 19.0%），FIRST CAPITAL INC自由现金流更多（$19.9M vs $3.0K），过去两年CUMBERLAND PHARMACEUTICALS INC的营收复合增速更高（26.9% vs 13.4%）
坎伯兰制药是一家专科制药企业，专注于开发、生产和商业化品牌处方药物，核心产品覆盖急症护理、胃肠病、疼痛管理及罕见病治疗领域，主要运营市场为美国，为相关医护人员与患者提供服务。
First Capital曾用名Future Capital Holdings，是印度一家非银行金融机构，主营债务融资业务。2018年12月，该机构与IDFC银行合并，组建IDFC第一银行，合并前其股票在印度国家证券交易所和孟买证券交易所挂牌上市。
CPIX vs FCAP — 直观对比
营收规模更大
CPIX
是对方的1.0倍
$13.5M
营收增速更快
CPIX
高出12.1%
19.0%
净利率更高
FCAP
高出46.5%
-10.3%
自由现金流更多
FCAP
多$19.9M
$3.0K
两年增速更快
CPIX
近两年复合增速
13.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $13.7M | $13.5M |
| 净利润 | $-1.4M | $4.9M |
| 毛利率 | 83.6% | — |
| 营业利润率 | -10.0% | — |
| 净利率 | -10.3% | 36.2% |
| 营收同比 | 31.1% | 19.0% |
| 净利润同比 | 25.8% | 49.6% |
| 每股收益（稀释后） | $-0.09 | $1.45 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CPIXFCAP
| Q4 25 | $13.7M | $13.5M | ||
| Q3 25 | $8.3M | $13.3M | ||
| Q2 25 | $10.8M | $12.4M | ||
| Q1 25 | $11.7M | $11.4M | ||
| Q4 24 | $10.4M | $11.3M | ||
| Q3 24 | $9.1M | $10.9M | ||
| Q2 24 | $9.8M | $10.7M | ||
| Q1 24 | $8.5M | $10.5M |
净利润CPIXFCAP
| Q4 25 | $-1.4M | $4.9M | ||
| Q3 25 | $-1.9M | $4.5M | ||
| Q2 25 | $-740.7K | $3.8M | ||
| Q1 25 | $1.3M | $3.2M | ||
| Q4 24 | $-1.9M | $3.3M | ||
| Q3 24 | $-1.5M | $2.9M | ||
| Q2 24 | $-1.1M | $2.8M | ||
| Q1 24 | $-1.9M | $3.0M |
毛利率CPIXFCAP
| Q4 25 | 83.6% | — | ||
| Q3 25 | 88.1% | — | ||
| Q2 25 | 81.4% | — | ||
| Q1 25 | 87.8% | — | ||
| Q4 24 | 81.1% | — | ||
| Q3 24 | 85.4% | — | ||
| Q2 24 | 82.6% | — | ||
| Q1 24 | 81.5% | — |
营业利润率CPIXFCAP
| Q4 25 | -10.0% | — | ||
| Q3 25 | -23.7% | 41.8% | ||
| Q2 25 | -6.9% | 37.2% | ||
| Q1 25 | 11.0% | 34.2% | ||
| Q4 24 | -17.7% | 34.8% | ||
| Q3 24 | -18.6% | 31.5% | ||
| Q2 24 | -10.4% | 31.1% | ||
| Q1 24 | -22.0% | 33.0% |
净利率CPIXFCAP
| Q4 25 | -10.3% | 36.2% | ||
| Q3 25 | -23.4% | 33.8% | ||
| Q2 25 | -6.8% | 30.4% | ||
| Q1 25 | 10.7% | 28.3% | ||
| Q4 24 | -18.2% | 28.8% | ||
| Q3 24 | -17.0% | 26.5% | ||
| Q2 24 | -11.0% | 26.5% | ||
| Q1 24 | -22.9% | 28.1% |
每股收益（稀释后）CPIXFCAP
| Q4 25 | $-0.09 | $1.45 | ||
| Q3 25 | $-0.13 | $1.34 | ||
| Q2 25 | $-0.05 | $1.13 | ||
| Q1 25 | $0.08 | $0.97 | ||
| Q4 24 | $-0.13 | $0.97 | ||
| Q3 24 | $-0.11 | $0.87 | ||
| Q2 24 | $-0.08 | $0.85 | ||
| Q1 24 | $-0.14 | $0.88 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $11.4M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $24.9M | $137.8M |
| 总资产 | $76.8M | $1.3B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CPIXFCAP
| Q4 25 | $11.4M | — | ||
| Q3 25 | $15.2M | — | ||
| Q2 25 | $16.1M | — | ||
| Q1 25 | $15.1M | — | ||
| Q4 24 | $18.0M | — | ||
| Q3 24 | $17.5M | — | ||
| Q2 24 | $17.3M | — | ||
| Q1 24 | $18.5M | — |
股东权益CPIXFCAP
| Q4 25 | $24.9M | $137.8M | ||
| Q3 25 | $26.1M | $132.4M | ||
| Q2 25 | $28.0M | $123.2M | ||
| Q1 25 | $28.7M | $120.1M | ||
| Q4 24 | $22.9M | $114.6M | ||
| Q3 24 | $24.8M | $116.8M | ||
| Q2 24 | $26.3M | $107.8M | ||
| Q1 24 | $27.5M | $105.7M |
总资产CPIXFCAP
| Q4 25 | $76.8M | $1.3B | ||
| Q3 25 | $65.9M | $1.2B | ||
| Q2 25 | $67.9M | $1.2B | ||
| Q1 25 | $69.9M | $1.2B | ||
| Q4 24 | $75.6M | $1.2B | ||
| Q3 24 | $76.7M | $1.2B | ||
| Q2 24 | $78.5M | $1.2B | ||
| Q1 24 | $81.5M | $1.2B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $3.0K | $21.3M |
| 自由现金流经营现金流 - 资本支出 | $3.0K | $19.9M |
| 自由现金流率自由现金流/营收 | 0.0% | 147.7% |
| 资本支出强度资本支出/营收 | 0.0% | 10.0% |
| 现金转化率经营现金流/净利润 | — | 4.36× |
| 过去12个月自由现金流最近4个季度 | $4.8M | $35.3M |
8季度趋势，按日历期对齐
经营现金流CPIXFCAP
| Q4 25 | $3.0K | $21.3M | ||
| Q3 25 | $187.2K | $7.9M | ||
| Q2 25 | $843.8K | $3.7M | ||
| Q1 25 | $3.9M | $4.4M | ||
| Q4 24 | $1.9M | $22.3M | ||
| Q3 24 | $475.5K | $7.6M | ||
| Q2 24 | $-855.7K | $3.5M | ||
| Q1 24 | $-2.1M | $7.2M |
自由现金流CPIXFCAP
| Q4 25 | $3.0K | $19.9M | ||
| Q3 25 | $163.4K | $7.8M | ||
| Q2 25 | $817.3K | $3.5M | ||
| Q1 25 | $3.9M | $4.2M | ||
| Q4 24 | $1.9M | $21.6M | ||
| Q3 24 | $460.1K | $7.5M | ||
| Q2 24 | $-862.8K | $3.3M | ||
| Q1 24 | $-2.2M | $7.1M |
自由现金流率CPIXFCAP
| Q4 25 | 0.0% | 147.7% | ||
| Q3 25 | 2.0% | 58.6% | ||
| Q2 25 | 7.5% | 27.8% | ||
| Q1 25 | 32.9% | 36.5% | ||
| Q4 24 | 18.2% | 190.7% | ||
| Q3 24 | 5.1% | 68.6% | ||
| Q2 24 | -8.8% | 31.2% | ||
| Q1 24 | -25.6% | 67.2% |
资本支出强度CPIXFCAP
| Q4 25 | 0.0% | 10.0% | ||
| Q3 25 | 0.3% | 1.2% | ||
| Q2 25 | 0.2% | 2.2% | ||
| Q1 25 | 0.4% | 1.9% | ||
| Q4 24 | 0.0% | 6.3% | ||
| Q3 24 | 0.2% | 0.8% | ||
| Q2 24 | 0.1% | 1.4% | ||
| Q1 24 | 0.5% | 1.5% |
现金转化率CPIXFCAP
| Q4 25 | — | 4.36× | ||
| Q3 25 | — | 1.77× | ||
| Q2 25 | — | 0.99× | ||
| Q1 25 | 3.10× | 1.36× | ||
| Q4 24 | — | 6.84× | ||
| Q3 24 | — | 2.62× | ||
| Q2 24 | — | 1.23× | ||
| Q1 24 | — | 2.45× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
